Godsey & Gibb Inc’s CRISPR Therapeutics CRSP Stock Holding History

Godsey & Gibb Inc’s Portfolio CRSP Stock Details CRSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.89K	Hold	108	–	–	﹤0.01%	304
2026 Q1	$5.14K	Hold	108	–	–	﹤0.01%	316
2025 Q4	$5.66K	Buy	+108	New	+$6.47K	﹤0.01%	333
2024 Q2	–	Sell	-45	Closed	-$3.07K	–	409
2024 Q1	$3.07K	Buy	+45	New	+$3.22K	﹤0.01%	334
2023 Q1	–	Sell	-200	Closed	-$8.13K	–	347
2022 Q4	$8.13K	Buy	+200	New	+$10.6K	﹤0.01%	213
2022 Q3	–	Sell	-190	Closed	-$12K	–	106
2022 Q2	$12K	Buy	+190	New	+$11.2K	0.01%	62

Other funds holding CRSP

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Wealth Enhancement Trust Services Sioux Falls, South Dakota $792M AUM

Handelsbanken Fonder

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Wealth Enhancement Advisory Services

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.6B AUM 29.42% 1-Year Est. Return

Brave Asset Management Summit, New Jersey $467M AUM 33.05% 1-Year Est. Return

180 Wealth Advisors Federal Way, Washington $997M AUM 47.84% 1-Year Est. Return

SteelPeak Wealth Woodland Hills, California $3.8B AUM 48.92% 1-Year Est. Return

Independent Financial Group San Diego, California $5.35B AUM 43.78% 1-Year Est. Return

IVC Wealth Advisors Silverdale, Pennsylvania $256M AUM 27.59% 1-Year Est. Return